Radiopharm Theranostics Limited Basic Earnings Loss Per Share From Continuing Operations
Radiopharm Theranostics Limited (RDPTF) reported Basic Earnings Loss Per Share From Continuing Operations of $38342457.00 per share for the 12-month period ending 2025-06-30, per its 20-F filed 2025-09-18.
Financial Statements › Income Statement › Earnings Per Share
ifrs-full:BasicEarningsLossPerShareFromContinuingOperations · last filed 2025-09-18
| Period end | Basic Earnings Loss Per Share From Continuing Operations 12 month |
|---|---|
| 2025-06-30 | $38342457.00 20-F · filed 2025-09-18 |
| 2024-06-30 | $47949119.00 20-F · filed 2025-09-18 |
| 2023-06-30 | $34611194.00 20-F · filed 2025-09-18 |